US Patent 8207179 Substituted indolines as tyrosine kinase inhibitors
Patent 8207179 was granted and assigned to Boehringer Ingelheim on June, 2012 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
June 9, 2008
Date of Patent
June 26, 2012
Patent Application Number
12664162
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 8207179 Substituted indolines as tyrosine kinase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
